The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Amenorrhea in Premenopausal Women After Adjuvant Chemotherapy for Breast Cancer
Abstract
Chemotherapy and ovarian ablation both independently improve survival in premenopausal women with hormone-sensitive breast cancer. Amenorrhea is a well-recognized occurrence after chemotherapy. The rate of chemotherapy-induced amenorrhea varies with patient age and chemotherapy regimens administered. However, the impact of chemotherapy-induced amenorrhea on prognosis is still being defined. Older studies in premenopausal women argue that the benefit with chemotherapy is a result of direct cytotoxicity alone. However, studies that restrict outcome analysis to hormone receptor–positive tumors suggest that chemotherapy has a dual mechanism in women with hormone-responsive tumors; indirect endocrine manipulation secondary to chemotherapy-induced ovarian suppression and direct cytotoxicity. The significant health ramifications involved with the induction of premature menopause as well as potential benefits necessitate a comprehensive evaluation of chemotherapy-induced amenorrhea. This review will discuss the incidence of amenorrhea with commonly-used adjuvant chemotherapeutic regimens, the possible benefits of chemotherapy-induced amenorrhea, and the challenges of interpreting the existing data in breast cancer trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Clinical gynecologic endocrinology and infertility
Fritz, M. A., & Speroff, L. (1983) · Cited by 2,099
Henderson, I. C., Berry, D. A., Demetri, G. D., Cirrincione, C. T., Goldstein, L. J., Martino, S., Ingle, J. N., Cooper, M. R., Hayes, D. F., Tkaczuk, K. H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.063 · Cited by 1,294
Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi326 · Cited by 1,127
Bonadonna, G., Valagussa, P., Moliterni, A., Zambetti, M., & Brambilla, C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321401 · Cited by 1,049
Adjuvant Docetaxel for Node-Positive Breast Cancer
Martin, M., Pienkowski, T., Mackey, J., Pawlicki, M., Guastalla, J.-P., Weaver, C., Tomiak, E., Al-Tweigeri, T., Chap, L., Juhos, E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043681 · Cited by 954
(2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.979 · Cited by 893
Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
Bines, J., Oleske, D. M., & Cobleigh, M. A. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1718 · Cited by 816
Levine, M. N., Bramwell, V. H., Pritchard, K. I., Norris, B. D., Shepherd, L. E., Abu-Zahra, H., Findlay, B., Warr, D., Bowman, D., Myles, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2651 · Cited by 617
Risk of Menopause During the First Year After Breast Cancer Diagnosis
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M., & Hood, N. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2365 · Cited by 606
Executive summary: Stages of Reproductive Aging Workshop (STRAW)
Soules, M. R., Sherman, S., Parrott, E., Rebar, R., Santoro, N., Utian, W., & Woods, N. (2001) · Climacteric · doi:10.1080/cmt.4.4.267.272 · Cited by 603
Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer
Budman, D. R., Berry, D. A., Cirrincione, C. T., Henderson, Wood, W. C., Weiss, R. B., Ferree, C. R., Muss, H. B., Green, M. R., Norton, L., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.16.1205 · Cited by 577
Ovarian ablation in early breast cancer: overview of the randomised trials
(1996) · The Lancet · doi:10.1016/s0140-6736(96)05023-4 · Cited by 561
Petrek, J. A., Naughton, M. J., Case, L. D., Paskett, E. D., Naftalis, E. Z., Singletary, S. E., & Sukumvanich, P. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3969 · Cited by 410
Cyclophosphamide-Induced Ovarian Failure
Warne, G. L., Fairley, K. F., Hobbs, J. B., & Martin, F. I. R. (1973) · New England Journal of Medicine · doi:10.1056/nejm197311292892202 · Cited by 405
Jonat, W., Kaufmann, M., Sauerbrei, W., Blamey, R., Cuzick, J., Namer, M., Fogelman, I., de Haes, J. C., de Matteis, A., Stewart, A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.042 · Cited by 341
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer
Bonadonna, G., Valagussa, P., Rossi, A., Tancini, G., Brambilla, C., Zambetti, M., & Veronesi, U. (1985) · Breast Cancer Research and Treatment · doi:10.1007/bf01805984 · Cited by 289
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
Aebi, S., Gelber, S., Castiglione-Gertsch, M., Gelber, R., Collins, J., Thürlimann, B., Rudenstam, C., Lindtner, J., Crivellari, D., Cortes-Funes, H., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02292-3 · Cited by 287
Fisher, B., Anderson, S., Tan-Chiu, E., Wolmark, N., Wickerham, D. L., Fisher, E. R., Dimitrov, N. V., Atkins, J. N., Abramson, N., Merajver, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.931 · Cited by 272
Persistent Mood Symptoms in a Multiethnic Community Cohort of Pre- and Perimenopausal Women
Bromberger, J. T. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg155 · Cited by 269
International Breast Cancer Study Group (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg119 · Cited by 264
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer
Rodenhuis, S., Bontenbal, M., Beex, L. V. A. M., Wagstaff, J., Richel, D. J., Nooij, M. A., Voest, E. E., Hupperets, P., van Tinteren, H., Peterse, H. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022794 · Cited by 258
Gracia, C. R., Sammel, M. D., Freeman, E. W., Lin, H., Langan, E., Kapoor, S., & Nelson, D. B. (2005) · Menopause · doi:10.1097/00042192-200512020-00005 · Cited by 251
(2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.0783 · Cited by 244
Pagani, O., O’Neill, A., Castiglione, M., Gelber, R. D., Goldhirsch, A., Rudenstam, C.-M., Lindtner, J., Collins, J., Crivellari, D., Coates, A., et al. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10036-3 · Cited by 227
Smith, I. E., Dowsett, M., Yap, Y.-S., Walsh, G., Lønning, P. E., Santen, R. J., & Hayes, D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3694 · Cited by 205
The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients
Goldhirsch, A., Gelber, R. D., & Castiglione, M. (1990) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057718 · Cited by 196
Dose-Dense Adjuvant Chemotherapy in Early Breast Cancer Patients: Results From a Randomized Trial
Venturini, M., Mastro, L. D., Aitini, E., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji398 · Cited by 154
Panel, N. I. O. H. C. D. (2001) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003460 · Cited by 153
Morphological study of the ovaries of leukaemic children
HIMELSTEIN-BRAW, R., Peters, H., & Faber, M. (1978) · British Journal of Cancer · doi:10.1038/bjc.1978.166 · Cited by 149
Fisher, B., Glass, A. G., Redmond, C. K., Fisher, E. R., BARTON, B. A., Such, E., Carbone, P. P., Economou, S. G., Foster, R. S., Frelick, R. W., et al. (1977) · Cancer · doi:10.1002/1097-0142(197706)39:6<2883::aid-cncr2820390676>3.0.co;2-9 · Cited by 149
Parulekar, W. R., Day, A. G., Ottaway, J., Shepherd, L. E., Trudeau, M., Bramwell, V. H. C., Levine, M. N., & Pritchard, K. I. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.096 · Cited by 130
Hortobágyi, G. N., Buzdar, A. U., Marcus, C., & Smith, T. L. (1986) · PubMed · Cited by 124
Nitz, U. A., Mohrmann, S., Fischer, J., Lindemann, W., Berdel, W. E., Jackisch, C., Werner, C., Ziske, C. G., Kirchner, H. H., Metzner, B., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67784-7 · Cited by 108
Burger, H. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00145-9 · Cited by 107
Goldhirsch, A., Stjemsward, J., Hartmann, W., Davis, B., Zava, D. T., Jordan, V. C., Zimmermann, A., Baggenstoss, A. H., Wiedmer, C., Ramminger, C., et al. (1985) · Cancer Research · Cited by 97
Boccardo, F., RUBAGOTTI, A., Bruzzi, P., Cappellini, M. D., Isola, G., Nenci, I., PIFFANELLI, A., Scanni, A., Sismondi, P., & Santi, L. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.8.1310 · Cited by 94
Adjuvant Endocrine Therapy for Premenopausal Women With Early Breast Cancer
Dellapasqua, S., Colleoni, M. A., Gelber, R. D., & Goldhirsch, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.050 · Cited by 77
Pituitary-ovarian function in breast cancer patients on adjuvant chemoimmunotherapy
Samaan, N. A., Deasis, D. N., Buzdar, A. U., & Blumenschein, G. R. (1978) · Cancer · Cited by 68
Endocrine profile in breast cancer patients receiving chemotherapy
Mehta, R. R., Beattie, C. W., & Gupta, T. K. D. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf01834642 · Cited by 61
Reyno, L. M., Levine, M. N., Skingley, P., et al. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90569-2 · Cited by 58
Swain, S. M., Land, S. R., Sundry, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.537 · Cited by 16
Self-citationIntravenous Iron and Recombinant Human Erythropoietin in Cancer Patients
Beguin, Y. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.184 · Cited by 12
Andrews, H. N., Habibi, G., Kucab, J. E., & Dunn, S. E. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-6941-5 · Cited by 7
Cited by
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2012) · The Lancet · doi:10.1016/s0140-6736(11)61625-5 · Cited by 2,089
Howard-Anderson, J., Ganz, P. A., Bower, J. E., & Stanton, A. L. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr541 · Cited by 830
Premature menopause or early menopause: Long-term health consequences
Shuster, L. T., Rhodes, D. J., Gostout, B. S., Grossardt, B. R., & Rocca, W. A. (2010) · Maturitas · doi:10.1016/j.maturitas.2009.08.003 · Cited by 808
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
Sparano, J. A., Gray, R. J., Ravdin, P. M., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1904819 · Cited by 532
Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival
Partridge, A. H., Hughes, M. E., Warner, E. T., Ottesen, R. A., Wong, Y.-N., Edge, S. B., Theriault, R. L., Blayney, D. W., Niland, J. C., Winer, E. P., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.8013 · Cited by 473
Metadata
- Authors
- Walshe, J. M., Denduluri, N., & Swain, S. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-12-20
- Volume
- 24
- Issue
- 36
- Pages
- 5769-5779
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2012182920
- Cited by
- 354
- References
- 45
- FWCI
- 19.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.